Lush Healthy

Lush Living, Healthy

Breaking News
• Cancer drains livelihoods in India • Everest Medicines expands portfolio with Sumecigrel in Asia-Pacific • Dual agonists break the pain safety trade-off • Manufacturing Advances Key to Therapy Breakthroughs • Samsung Bioepis Launches Ustekinumab Biosimilar in Japan

Hot Stories

Nippon Shinyaku and Elixirgen partner on Duchenne drug
Clean Beauty

Nippon Shinyaku and Elixirgen partner on Duchenne drug

Nippon Shinyaku and Elixirgen partner on a Duchenne drug option, securing global rights for the experimental therapy EXG-7001 to treat muscular dystrophy.

By Syakirah Wahab Jul 19, 2026

Clean Beauty

View All

Glow Health

Sanyou Bio and Baiyunshan form new partnership
Glow Health

Sanyou Bio and Baiyunshan form new partnership

Sanyou Bio forms new partnership with Baiyunshan to co-develop novel radiopharmaceuticals and radiodiagnostic products through AI-driven discovery platforms.

By Qistina Anuar Jul 16, 2026

Herbal Picks

View All
Everest Medicines expands portfolio with Sumecigrel in Asia-Pacific

Everest Medicines expands portfolio with Sumecigrel in Asia-Pacific

Jul 24, 2026
Dual agonists break the pain safety trade-off

Dual agonists break the pain safety trade-off

Jul 22, 2026
Samsung Bioepis Launches Ustekinumab Biosimilar in Japan

Samsung Bioepis Launches Ustekinumab Biosimilar in Japan

Jul 20, 2026
Taipei Wins Global Biotech Hub Status

Taipei Wins Global Biotech Hub Status

Jul 18, 2026

Natural Remedies

All Stories

Skin Wellness

All Stories

All Post

Cancer drains livelihoods in India

Cancer drains livelihoods in India

By Qistina Anuar July 24, 2026
Cancer treatment costs in India push survivors into debt and financial hardship despite rising survival rates.
Everest Medicines expands portfolio with Sumecigrel in Asia-Pacific

Everest Medicines expands portfolio with Sumecigrel in Asia-Pacific

By Qistina Anuar July 24, 2026
Everest Medicines expands portfolio with Sumecigrel across Asia-Pacific. Learn about the exclusive licensing deal and financial terms.
Dual agonists break the pain safety trade-off

Dual agonists break the pain safety trade-off

By Maisarah Talib July 22, 2026
Discover how dual agonists are reshaping pain management by breaking the safety trade-off for safer therapies today.
Manufacturing Advances Key to Therapy Breakthroughs

Manufacturing Advances Key to Therapy Breakthroughs

By Qistina Anuar July 20, 2026
Discover how digital manufacturing advances are solving key bottlenecks in cell and gene therapy scale-up to enable breakthroughs.
Samsung Bioepis Launches Ustekinumab Biosimilar in Japan

Samsung Bioepis Launches Ustekinumab Biosimilar in Japan

By Maisarah Talib July 20, 2026
Samsung Bioepis begins selling ustekinumab biosimilar in Japan with Nipro. See how this partnership impacts the market and what it means for patients.
Nippon Shinyaku and Elixirgen partner on Duchenne drug

Nippon Shinyaku and Elixirgen partner on Duchenne drug

By Syakirah Wahab July 19, 2026
Nippon Shinyaku and Elixirgen partner on a Duchenne drug option, securing global rights for the experimental therapy EXG-7001 to treat muscular dystrophy.
International Women’s Day Issues Wake-Up Call

International Women’s Day Issues Wake-Up Call

By Qistina Anuar July 19, 2026
On International Women's Day, a life science leader calls the funding gap for women's health research an embarrassment. Discover the shocking stats.
Taipei Wins Global Biotech Hub Status

Taipei Wins Global Biotech Hub Status

By Qistina Anuar July 18, 2026
Taipei wins global biotech hub status, repositioning itself from chip-making to biotech destination as a major biotech hub.
Gulf Medical University opens new simulation hubs

Gulf Medical University opens new simulation hubs

By Qistina Anuar July 17, 2026
Gulf Medical University opens new simulation hubs for hands-on learning and clinical skills training with dedicated facilities.
Sanyou Bio and Baiyunshan form new partnership

Sanyou Bio and Baiyunshan form new partnership

By Qistina Anuar July 16, 2026
Sanyou Bio forms new partnership with Baiyunshan to co-develop novel radiopharmaceuticals and radiodiagnostic products through AI-driven discovery platforms.
1 2 3
© 2026 Lush Healthy. All rights reserved.